logo

For the Inventor, By the Inventor

Seattle, WA, United States of America

Rosetta Inpharmatics, Inc.


USPTO Granted Patents = 47

% Expired Patents = 25.5



Forward Citations = 1,680

Loading Chart...
Loading Chart...

47 inventors (with patents filed for the assignee):

goldMedal Roland Stoughton (21 out of 30 patents)

silverMedal Stephen H Friend (15 out of 30 patents)

bronzeMedal HongYue Dai (5 out of 9 patents)

4.  Yudong He (5 out of 10 patents)

5.  Christopher J Roberts (5 out of 7 patents)

6.  Peter S Linsley (5 out of 77 patents)

7.  Julja Burchard (4 out of 10 patents)

8.  Andrey Bondarenko (4 out of 4 patents)

9.  Christopher D Armour (3 out of 9 patents)

10.  Douglas E Bassett, Jr (3 out of 5 patents)

11.  Mao Mao (3 out of 5 patents)

12.  Matthew Marton (3 out of 5 patents)

13.  Daniel D Shoemaker (3 out of 26 patents)

14.  Matthew N Ashby (2 out of 15 patents)

15.  Laura Johanna Van't Veer (2 out of 6 patents)


Core Competencies:
Chronic Myeloid Leukemia
Microarrays
Gene Expression
Breast Cancer
Oligonucleotides
Protein Activity
Drug Screening
Biological Measurements
Therapeutic Index
Antifungal Compounds
Measurement Errors
Biological Networks

47 patents:

1. 8014957 - Genes associated with progression and response in chronic myeloid leukemia and uses thereof (2011-09-06),
2. 7569343 - Methods to assess quality of microarrays (2009-08-04),
3. 7565251 - Systems and methods for evaluating the significance of differences in biological measurements (2009-07-21),
4. 7514209 - Diagnosis and prognosis of breast cancer patients (2009-04-07),
5. 7432084 - Methods for preparing nucleic acid samples (2008-10-07),
6. 7418351 - Methods for analysis of measurement errors in measured signals (2008-08-26),
7. 7371516 - Methods for determining the specificity and sensitivity of oligonucleo tides for hybridization (2008-05-13),
8. 7294478 - Microarray reaction cartridge (2007-11-13),
9. 7269517 - Computer systems and methods for analyzing experiment design (2007-09-11),
10. 7254487 - Methods for determining therapeutic index from gene expression profiles (2007-08-07),
11. 7229765 - [object Object] (2007-06-12),
12. 7171311 - Methods of assigning treatment to breast cancer patients (2007-01-30),
13. 7150969 - Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2) (2006-12-19),
14. 7141398 - Methods for recycling mRNA for linear cRNA amplification (2006-11-28),
15. 7130746 - Computer systems and computer programs for determining protein activity levels using gene expression profiles (2006-10-31),
Company Overview
Rosetta Inpharmatics, Inc., based in Seattle, WA, specializes in advanced genomic technologies aimed at enhancing cancer diagnosis and treatment. The company focuses on chronic myeloid leukemia and breast cancer, utilizing microarrays and gene expression profiles to develop innovative solutions for drug screening and biological response analysis. Their expertise in oligonucleotide specificity and RNA amplification positions them at the forefront of personalized medicine, contributing significantly to the understanding and management of complex diseases.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

47 Patents

#58 in Seattle, WA

#173 in Washington

#7,440 in US

#14,827 in the World

Seattle, WA (US)
Seattle, WA, United States of America

Rosetta Inpharmatics, Inc.

Forward Citations = 1,680

47 inventors:

goldMedal Roland Stoughton (21 out of 30 patents)

silverMedal Stephen H Friend (15 out of 30 patents)

bronzeMedal HongYue Dai (5 out of 9 patents)

4.  Yudong He (5 out of 10 patents)

5.  Christopher J Roberts (5 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rosetta Inpharmatics, Inc.. Retrieved from https://idiyas.com/company/rosetta-inpharmatics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…